Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Acciavatti, Raymond Joseph

University Of Pennsylvania
United States

Next-Generation Tomosynthesis Pilot Study 5R37CA273959-04 Asad Umar, D.V.M., Ph.D.
Acharya, Munjal M

University Of California-Irvine
United States

Stem cell-derived exosomes to ameliorate chemobrain 5R01CA262213-03 Rachel Altshuler, Ph.D.
Acharya, Munjal M

University Of California-Irvine
United States

Stem cell-derived exosomes to ameliorate chemobrain 5R01CA262213-03 Rachel Altshuler, Ph.D.
Acoba, Jared

University Of Hawaii At Manoa
United States

The Hawaii Minority/Underserved NCORP 3UG1CA189804-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Acoba, Jared

University Of Hawaii At Manoa
United States

The Hawaii Minority/Underserved NCORP 3UG1CA189804-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Adams-Campbell, Lucile Lauren

Georgetown University
United States

National Capital Area (NCA) NCI Community Oncology Research Program (NCORP) 3UG1CA239758-06S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Adams-Campbell, Lucile Lauren

Georgetown University
United States

National Capital Area (NCA) NCI Community Oncology Research Program (NCORP) 3UG1CA239758-06S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Adebamowo, Clement Adebayo

University Of Maryland Baltimore
United States

Baltimore CASCADE Study Site (BaCSS Project) 5UG1CA284883-03 Maria Silvina Frech, Ph.D., M.S.
Afshar-Kharghan, Vahid

University Of Tx Md Anderson Can Ctr
United States

Novel Biomarkers Predicting Blood Clots in Ovarian Cancer 5R01CA275762-03 Rachel Altshuler, Ph.D.
Afshar-Kharghan, Vahid

University Of Tx Md Anderson Can Ctr
United States

Novel Biomarkers Predicting Blood Clots in Ovarian Cancer 5R01CA275762-03 Rachel Altshuler, Ph.D.
Ah, Diane Marie Von

Ohio State University
United States

Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial 5R01CA276222-03 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ah, Diane Marie Von

Ohio State University
United States

Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial 5R01CA276222-03 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ahn, Eun Hyun

Johns Hopkins University
United States

Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents 5R01CA279948-02 Guillermo Marquez, Ph.D.
Ahn, Jiyoung

New York University School Of Medicine
United States

The Oral Mycobiome and Risk of Pancreatic Cancer 5U01CA250186-04 Claire Zhu, Ph.D.
Alambeigi, Farshid

University Of Texas At Austin
United States

A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps 5R21CA280747-02 Matthew Young, Ph.D.